Leflunomide
Product Images NDC 68258-2992

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Leflunomide (NDC 68258-2992). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

64c92eb9-figure-01 (64c92eb9 Figure 01)

64c92eb9-figure-01 (64c92eb9 Figure 01)
FDA Label Image

64c92eb9-figure-02 (64c92eb9 Figure 02)

64c92eb9-figure-02 (64c92eb9 Figure 02)
FDA Label Image

64c92eb9-figure-03 (64c92eb9 Figure 03)

64c92eb9-figure-03 (64c92eb9 Figure 03)
FDA Label Image

64c92eb9-figure-04. (64c92eb9 Figure 04)

64c92eb9-figure-04. (64c92eb9 Figure 04)
FDA Label Image

64c92eb9-figure-05 (64c92eb9 Figure 05)

64c92eb9-figure-05 (64c92eb9 Figure 05)
FDA Label Image

64c92eb9-figure-06 (64c92eb9 Figure 06)

64c92eb9-figure-06 (64c92eb9 Figure 06)
This text seems to be describing an improvement in functional ability measure, as indicated by a trial that was conducted with several groups. The text also mentions the HAQ Disability Index, LeLefluncride, M=bethotrexate, Placebs, and S-Sulfasslazine as potential factors related to this improvement, although it is unclear how they were involved.*
FDA Label Image

Ndc 68258-2992-03 (Ndc 68258 2992 03 Heritage)

Ndc 68258-2992-03 (Ndc 68258 2992 03 Heritage)
This is a description of pharmaceutical product packaging and labeling. The text includes information about a bulk source data and a product ID for Heritage Pharmaceuticals Inc., as well as the NDC, mfr. lot, and pedigree # for a specific tablet. Instructions for dispensing and taking the tablet are also listed, along with warnings and precautions for potential side effects. Specific information about Leflunomide 20 mg tablets is also provided, including the Rev. Date, pregnancy exclusion requirement, and warning to keep out of children's reach. The text may be associated with the DispenseQuick system for distributing medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.